Lack of species-specific difference in pulmonary function when using mouse versus human plasma in a mouse model of hemorrhagic shock

被引:9
作者
Peng, Zhanglong [1 ]
Pati, Shibani [2 ]
Fontaine, Magali J. [3 ]
Hall, Kelly
Herrera, Anthony V. [4 ]
Kozar, Rosemary A. [4 ]
机构
[1] Univ Texas Houston, Dept Anesthesia, Houston, TX USA
[2] Blood Syst Res Inst, San Francisco, CA USA
[3] Univ Maryland, Dept Pathol, Baltimore, MD 21201 USA
[4] Univ Maryland, Ctr Shock Trauma, Baltimore, MD 21201 USA
关键词
Hemorrhagic shock in mice; lyophilized plasma; transfusion reaction; FRESH-FROZEN PLASMA; DAMAGE CONTROL RESUSCITATION; RANDOMIZED CLINICAL-TRIAL; SPRAY-DRIED PLASMA; TRAUMA; PERMEABILITY; INFLAMMATION; XENOTRANSPLANTATION; TRANSFUSION; CELLS;
D O I
10.1097/TA.0000000000001221
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Clinical studies have demonstrated that the early and empiric use of plasma improves survival after hemorrhagic shock. We have demonstrated in rodent models of hemorrhagic shock that resuscitation with plasma is protective to the lungs compared with lactated Ringer's solution. As our long-term objective is to determine themolecular mechanisms thatmodulate plasma's protective effects in injured bleeding patients, we have used human plasma in a mouse model of hemorrhagic shock. The goal of the current experiments is to determine if there are significant adverse effects on lung injurywhen using human versus mouse plasma in an establishedmurinemodel of hemorrhagic shock and laparotomy. METHODS: Mice underwent laparotomy and 90 minutes of hemorrhagic shock to a mean arterial pressure (MAP) of 35 +/- 5 mm Hg followed by resuscitation at 1 x shed blood using either mouse fresh frozen plasma (FFP), human FFP, or human lyophilized plasma. Mean arterial pressure was recorded during shock and for the first 30 minutes of resuscitation. After 3 hours, animals were killed, and lungs collected for analysis. RESULTS: There was a significant increase in early MAP when mouse FFP was used to resuscitate animals compared with human FFP or human lyophilized plasma. However, despite these differences, analysis of the mouse lungs revealed no significant differences in pulmonary histopathology, lung permeability, or lung edema between all three plasma groups. Analysis of neutrophil infiltration in the lungs revealed that mouse FFP decreased neutrophil influx as measured by neutrophil staining; however, myeloperoxidase immunostaining revealed no significant differences in between groups. CONCLUSION: The study of human plasma in a mouse model of hemorrhagic shock is feasible but does reveal some differences compared with mouse plasma-based resuscitation in physiologic measures such as MAP postresuscitation. Measures of end organ function such as lung injury appear to be comparable in this acute model of hemorrhagic shock and resuscitation. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:S171 / S176
页数:6
相关论文
共 24 条
  • [1] PLASMA-MEDIATED GUT PROTECTION AFTER HEMORRHAGIC SHOCK IS LESSENED IN SYNDECAN-1-/- MICE
    Ban, Kechen
    Peng, Zhanglong
    Pati, Shibani
    Witkov, Richard B.
    Park, Pyong Woo
    Kozar, Rosemary A.
    [J]. SHOCK, 2015, 44 (05): : 452 - 457
  • [2] COMBAT: INITIAL EXPERIENCE WITH A RANDOMIZED CLINICAL TRIAL OF PLASMA-BASED RESUSCITATION IN THE FIELD FOR TRAUMATIC HEMORRHAGIC SHOCK
    Chapman, Michael P.
    Moore, Ernest E.
    Chin, Theresa L.
    Ghasabyan, Arsen
    Chandler, James
    Stringham, John
    Gonzalez, Eduardo
    Moore, Hunter B.
    Banerjee, Anirban
    Silliman, Christopher C.
    Sauaia, Angela
    [J]. SHOCK, 2015, 44 : 63 - 70
  • [3] A brief history of clinical xenotransplantation
    Cooper, David K. C.
    Ekser, Burcin
    Tector, A. Joseph
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2015, 23 : 205 - 210
  • [4] Damage Control Resuscitation Is Associated With a Reduction in Resuscitation Volumes and Improvement in Survival in 390 Damage Control Laparotomy Patients
    Cotton, Bryan A.
    Reddy, Neeti
    Hatch, Quinton M.
    LeFebvre, Eric
    Wade, Charles E.
    Kozar, Rosemary A.
    Gill, Brijesh S.
    Albarado, Rondel
    McNutt, Michelle K.
    Holcomb, John B.
    [J]. ANNALS OF SURGERY, 2011, 254 (04) : 598 - 605
  • [5] Death on the battlefield (2001-2011): Implications for the future of combat casualty care
    Eastridge, Brian J.
    Mabry, Robert L.
    Seguin, Peter
    Cantrell, Joyce
    Tops, Terrill
    Uribe, Paul
    Mallett, Olga
    Zubko, Tamara
    Oetjen-Gerdes, Lynne
    Rasmussen, Todd E.
    Butler, Frank K.
    Kotwal, Russell S.
    Holcomb, John B.
    Wade, Charles
    Champion, Howard
    Lawnick, Mimi
    Moores, Leon
    Blackbourne, Lorne H.
    [J]. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2012, 73 : S431 - S437
  • [6] The α-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy
    Galili, U
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2005, 83 (06) : 674 - 686
  • [7] Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q
    Hart, ML
    Ceonzo, KA
    Shaffer, LA
    Takahashi, K
    Rother, RP
    Reenstra, WR
    Buras, JA
    Stahl, GL
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (10) : 6373 - 6380
  • [8] Modulation of Syndecan-1 Shedding after Hemorrhagic Shock and Resuscitation
    Haywood-Watson, Ricky J.
    Holcomb, John B.
    Gonzalez, Ernest A.
    Peng, Zhanglong
    Pati, Shibani
    Park, Pyong Woo
    Wang, WeiWei
    Zaske, Ana Maria
    Menge, Tyler
    Kozar, Rosemary A.
    [J]. PLOS ONE, 2011, 6 (08):
  • [9] Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients
    Holcomb, John B.
    Wade, Charles E.
    Michalek, Joel E.
    Chisholm, Gary B.
    Zarzabal, Lee Ann
    Schreiber, Martin A.
    Gonzalez, Ernest A.
    Pomper, Gregory. J.
    Perkins, Jeremy G.
    Spinella, Phillip C.
    Williams, Kari L.
    Park, Myung S.
    [J]. ANNALS OF SURGERY, 2008, 248 (03) : 447 - 456
  • [10] Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma The PROPPR Randomized Clinical Trial
    Holcomb, John B.
    Tilley, Barbara C.
    Baraniuk, Sarah
    Fox, Erin E.
    Wade, Charles E.
    Podbielski, Jeanette M.
    del Junco, Deborah J.
    Brasel, Karen J.
    Bulger, Eileen M.
    Callcut, Rachael A.
    Cohen, Mitchell Jay
    Cotton, Bryan A.
    Fabian, Timothy C.
    Inaba, Kenji
    Kerby, Jeffrey D.
    Muskat, Peter
    O'Keeffe, Terence
    Rizoli, Sandro
    Robinson, Bryce R. H.
    Scalea, Thomas M.
    Schreiber, Martin A.
    Stein, Deborah M.
    Weinberg, Jordan A.
    Callum, Jeannie L.
    Hess, John R.
    Matijevic, Nena
    Miller, Christopher N.
    Pittet, Jean-Francois
    Hoyt, David B.
    Pearson, Gail D.
    Leroux, Brian
    van Belle, Gerald
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (05): : 471 - 482